User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 02:42, 15 February 2015 (diff | hist) . . (+1,444) . . N JWH-019 (Created page with "JWH-019 is an analgesic chemical from the naphthoylindole family that acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is the N1-hexyl homologue of...")
- 02:37, 15 February 2015 (diff | hist) . . (+413) . . N JWH-081 (Created page with "JWH-081 is an analgesic chemical from the naphthoylindole family, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. With a Ki of 1.2nM it is fairl...") (current)
- 02:35, 15 February 2015 (diff | hist) . . (+12) . . JWH-073 (current)
- 02:33, 15 February 2015 (diff | hist) . . (+2,517) . . N JWH-073 (Created page with "'''JWH-073''' is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. It is somewhat...")
- 02:28, 15 February 2015 (diff | hist) . . (+30) . . N CP 47,497 (Created page with "See at Cannabicyclohexanol")
- 02:27, 15 February 2015 (diff | hist) . . (+806) . . N Cannabicyclohexanol (Created page with "'''Cannabicyclohexanol (CCH, CP 47,497 dimethyloctyl homologue, (C8)-CP 47,497)''' is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On 19 January 2009, the...")
- 02:06, 15 February 2015 (diff | hist) . . (+12) . . Synthetic Cannabis (→Australasia) (current)
- 02:06, 15 February 2015 (diff | hist) . . (+32) . . Synthetic Cannabis (→North America)
- 02:02, 15 February 2015 (diff | hist) . . (+391) . . N O-2372 (Created page with "O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB1 and CB2 receptors, with Ki valu...") (current)
- 02:01, 15 February 2015 (diff | hist) . . (+506) . . N O-2050 (Created page with "O-2050 is a drug that is a classical cannabinoid derivative, which acts as a silent antagonist for the CB1 receptor. This gives it an advantage in research over many commo...") (current)
- 01:59, 15 February 2015 (diff | hist) . . (+241) . . N O-2113 (Created page with "O-2113 is a drug that is a classical cannabinoid derivative, which acts as a potent agonist for cannabinoid receptors, producing sedation, hypothermia and analgesia in ani...")
- 01:58, 15 February 2015 (diff | hist) . . (+394) . . N O-2545 (Created page with "O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water soluble, whi...") (current)
- 01:56, 15 February 2015 (diff | hist) . . (0) . . O-2694 (current)
- 01:56, 15 February 2015 (diff | hist) . . (+692) . . N O-2694 (Created page with "O-2694 is a drug that is a cannabinoid derivative. It has analgesic effects and is used in scientific research. Unlike most cannabinoids discovered to date, it is highly w...")
- 01:52, 15 February 2015 (diff | hist) . . (+251) . . N O-774 (Created page with "O-774 is a classical cannabinoid derivative which acts as a potent agonist for the cannabinoid receptors, with a Ki of 0.6 nM at CB1, and very potent cannabinoid effec...") (current)
- 01:50, 15 February 2015 (diff | hist) . . (+425) . . N O-1057 (Created page with "O-1057 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water soluble, whi...") (current)
- 01:48, 15 February 2015 (diff | hist) . . (+259) . . N AM-2232 (Created page with "'''AM-2232 (1-(4-cyanobutyl)-3-(naphthalen-1-oyl)indole)''' is a drug that acts as a potent but unselective agonist for the cannabinoid receptors, with a Ki of 0.28nM at [...") (current)
- 01:44, 15 February 2015 (diff | hist) . . (+1,608) . . N 9-nor-9β-Hydroxyhexahydrocannabinol (Created page with "'''9-nor-9β-Hydroxyhexahydrocannabinol (HHC)''', is a synthetic cannabinoid derivative which resulted from early modifications to the structure of THC, in a search for th...")
- 19:21, 14 February 2015 (diff | hist) . . (+938) . . N STS-135 (drug) (Created page with "'''STS-135 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide)''' is a designer drug offered by online vendors as a cannabimimetic agent. The structure of STS-135...") (current)
- 19:16, 14 February 2015 (diff | hist) . . (+295) . . N ADB-PINACA (Created page with "ADB-PINACA is a cannabinoid designer drug that is an ingredient in some synthetic cannabis products. It has been linked to multiple hospitalizations due to its use. In the...") (current)
- 19:13, 14 February 2015 (diff | hist) . . (-14) . . AMG-41 (current)
- 19:11, 14 February 2015 (diff | hist) . . (+299) . . N AMG-36 (Created page with "'''AMG-36''' is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8THC substituted with a cyclopentane group on the 3-position side chain. AMG-36 i...") (current)
- 19:09, 14 February 2015 (diff | hist) . . (+297) . . N AMG-41 (Created page with "AMG-36 is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8THC substituted with a cyclopentane group on the 3-position side chain. AMG-36 is...")
- 18:34, 14 February 2015 (diff | hist) . . (0) . . ADBICA (current)
- 18:33, 14 February 2015 (diff | hist) . . (+808) . . N ADBICA (Created page with "ADBICA is a designer drug identified in synthetic cannabis blends in Japan in 2013. ADBICA had not previously been reported in the scientific literature prior to its sale...")
- 18:32, 14 February 2015 (diff | hist) . . (+18) . . N APICA (Created page with "See at SDB-001")
- 18:30, 14 February 2015 (diff | hist) . . (0) . . SDB-001
- 18:30, 14 February 2015 (diff | hist) . . (+1,224) . . N SDB-001 (Created page with "'''SDB-001 (2NE1, APICA, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide)''' is a drug that acts as a potent agonist for the cannabinoid receptors. It had never previousl...")
- 18:27, 14 February 2015 (diff | hist) . . (+814) . . N ADB-FUBINACA (Created page with "'''ADB-FUBINACA''' is a designer drug identified in synthetic cannabis blends in Japan in 2013. The (S) enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/1069...")
- 18:24, 14 February 2015 (diff | hist) . . (-2) . . AB-CHMINACA (current)
- 18:24, 14 February 2015 (diff | hist) . . (+426) . . N AB-CHMINACA (Created page with "AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor. == Side Effects == There have been a number of reported cases of sei...")
- 18:21, 14 February 2015 (diff | hist) . . (+1,246) . . N APINACA (Created page with "'''AKB48 (APINACA, N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide)''' is a drug that acts as a reasonably potent agonist for the cannabinoid receptors, with a Ki of 3...") (current)
- 18:18, 14 February 2015 (diff | hist) . . (+527) . . N AB-PINACA (Created page with "AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012. The pharmacological properties of this compound have not...") (current)
- 18:16, 14 February 2015 (diff | hist) . . (+360) . . N PF-03550096 (Created page with "PF-03550096 is a drug that acts as a potent agonist for the CB2 cannabinoid receptor, with good selectivity over CB1 having Ki values of 7nM at CB2 and 1500nM at CB1....") (current)
- 18:14, 14 February 2015 (diff | hist) . . (+486) . . N MDA-19 (Created page with "MDA-19 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with reasonable selectivity over the psychoactive CB1 receptor, though w...") (current)
- 18:12, 14 February 2015 (diff | hist) . . (+1,129) . . N JWH-203 (Created page with "'''JWH-203''' (1-pentyl-3-(2-chlorophenylacetyl)indole) is an analgesic chemical from the phenylacetylindole family that acts as a cannabinoid agonist with approximately e...")
- 17:01, 14 February 2015 (diff | hist) . . (+15) . . RCS-8 (current)
- 16:41, 14 February 2015 (diff | hist) . . (+2,002) . . N AM-2201 (Created page with "'''AM-2201''' (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a research chemical that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of...") (current)
- 16:30, 14 February 2015 (diff | hist) . . (+1,284) . . N AM-694 (Created page with "'''AM-694''' (1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole) is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB1. It is used in scientific...") (current)
- 16:27, 14 February 2015 (diff | hist) . . (+2) . . AM-679 (cannabinoid) (current)
- 16:27, 14 February 2015 (diff | hist) . . (+805) . . N AM-679 (cannabinoid) (Created page with "AM-679 is a drug that acts as a moderately potent agonist for the cannabinoid receptors, with a Ki of 13.5nM at CB1 and 49.5nM at CB2. AM-679 was one of the first...")
- 16:23, 14 February 2015 (diff | hist) . . (+565) . . N Cannabipiperidiethanone (Created page with "Cannabipiperidiethanone, (CPE, or 1-(N-methylpiperidin-2-ylmethyl)-3-(2-methoxyphenylacetyl)indole), is a synthetic cannabinoid that has been found as an ingredient of "he...") (current)
- 16:21, 14 February 2015 (diff | hist) . . (-4) . . AM-2233 (current)
- 16:15, 14 February 2015 (diff | hist) . . (+1,317) . . N N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide (Created page with "7-methoxy-1-(2-morpholinoethyl)-N-((1S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-indole-3-carboxamide (N-[(S)-fenchyl]-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-car...")
- 15:57, 14 February 2015 (diff | hist) . . (0) . . Rimonabant (current)
- 15:57, 14 February 2015 (diff | hist) . . (+31) . . Rimonabant (→Preparation)
- 15:56, 14 February 2015 (diff | hist) . . (+6,629) . . N Rimonabant (Created page with "Rimonabant (also known as SR141716; trade name Acomplia) is an anorectic antiobesity drug that has been withdrawn from the market due to potentially serious side effects....")
- 15:50, 14 February 2015 (diff | hist) . . (+21) . . N SR141716 (Created page with "See as Rimonabant") (current)
- 15:48, 14 February 2015 (diff | hist) . . (+80) . . NESS-0327 (current)
- 15:46, 14 February 2015 (diff | hist) . . (+715) . . N NESS-0327 (Created page with "NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB1. It is much more potent an antagonis...")
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
